SCARLETT MIKESELL-PIERCE: Open Payments
NPI 1497352991 · HENRYVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$960 in 49 payments from 14 companies in 2025. Trend: 2023 $1,053 · 2024 $227 · 2025 $960
Food & beverage: $960
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $325 |
| Novo Nordisk Inc | 7 | $127 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $99 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $74 |
| ViiV Healthcare Company | 3 | $58 |
| Otsuka America Pharmaceutical, Inc. | 3 | $48 |
| Lundbeck LLC | 2 | $40 |
| Alkermes, Inc. | 2 | $37 |
| Exact Sciences Corporation | 2 | $36 |
| Gilead Sciences, Inc. | 2 | $33 |
Products named: VRAYLAR, TRINTELLIX, REXULTI, Kerendia, MAVYRET, DOVATO, Rybelsus, UBRELVY.
Industry payments across IN — which companies pay providers there.
